Abstract
Many bacterial pathogens express cell surface polysaccharides which protect the bacterium during the initial stages of infection and hide the cell surface from innate host immune defense mechanisms. In some cases, pre-existing antibodies directed against these cell surface polysaccharides protect against infection: in these cases the purified polysaccharides can be used as prophylactic vaccines. Purified polysaccharide vaccines prepared from capsular polysaccharides (CPSs) present several unique features. The polysaccharides are relatively simple, and, in the absence of accessible animal models, quality control is largely based on physicochemical and immunochemical methods, and dosage is in SI units. As protection is serotype- (or serogroup-) specific, polysaccharide vaccines are often blends of multiple polysaccharides derived from different strains, e.g., 23 in the case of pneumococcal vaccines. Critical quality attributes for these vaccines are polysaccharide identity, polysaccharide molecular size, and safety factors (such as pyrogenicity). As T cell-independent Type II immunogens, these vaccines fail to invoke immunological memory, so that repeat immunization is required. They are poorly immunogenic in infants, the principal risk group for many of these infections, and technologies such as saccharide conjugation to carrier proteins have been developed to protect this group, while polysaccharide vaccines continue to be used in adolescents and adults. In this chapter, we present background on the physical chemical nature of bacterial polysaccharides, their Critical Quality Attributes (CQA’s), and the analytical methodologies applied to their structural and physical characterization as well as to measure their CQA’s.
Keywords
- Sialic Acid
- Conjugate Vaccine
- Capillary Zone Electrophoresis
- Capsular Polysaccharide
- Bacterial Polysaccharide
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abeygunwardana C, Williams TC, Sumner JS, Hennessey JP Jr (2000) Anal Biochem 279:226–240
Akoka S, Barantin L, Trierweiler M (1999) Anal Chem 71:2554–2557
Anthon G, Barrett D (2003) J Sci Food Agric 83:1210–1213
Bardotti A, Averani G, Berti F, Berti S, Carinci V, D’Ascenzi S, Fabbri B, Giannini S, Giannozzi A, Magagnoli C, Proietti D, Norelli F, Rappuoli R, Ricci S, Costantino P (2008) Vaccine 26:2284–2296
Bardotti A, Ravenscroft N, D’Ascenzi S, Averani G (2000) Vaccine 18:1982–1993
Bartlett GR (1959) J Biol Chem 234:466–468
Bednar B, Hennessey JP (1993) Carbohydr Res 243:115–130
Beynon LM, Richards JC, Perry MB (1997) Eur J Biochem 250:163–167
Blumenkrantz N, Asboe-Hansen G (1976) Clin Biochem 9:269–274
Bourgoin A, Zablackis E, Poli JB (2008) Food Hydrocolloids 22:1607–1611
Bussat B, Schultz Arminjon R, Valentin C, Armand J (1990) Biologicals 18:117–121
Calix JJ, Nahm MH, Zartler ER (2011) J Bacteriol 193:5271–5278
Calix JJ, Nahm MN, Zartler ER (2012a) J Bacteriol 194:206
Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, Abeygunwardana C, Nahm MH (2012b) J Biol Chem 287:27885–27894
Canaan-Haden L, Cremata J, Chang J, Valeds Y, Cardoso F, Bencomo VV (2006) Vaccine 24S2:S2/70–S2/71
Chang J, Serrano Y, Garrido R, Rodriguez LM, Pedroso J, Cardoso F, Valdes Y, Garcia D, Fernandez-Santana V, Verez-Bencomo V (2012) Vaccine 30:7090–7096
Chen PS, Toribana TY, Warner H (1956) Anal Chem 28:1756
Fiske CH, SubbaRow YJ (1925) J Biol Chem 66:375
Foschiatti M, Hearshaw M, Cescutti P, Ravenscroft N, Rizzo R (2009) Carbohydr Res 344:940–943
Friedemann TE, Haugen GE (1943) J Biol Chem 147:415–442
Gregory JD (1960) Arch Biochem Biophys 89:157–159
Haan A, Put RM, Beurret M (2013) Biomed Chromatogr 27:1137–1142
Hadjivassiliouk AG, Rieder SV (1968) Clin Chim Acta 19:357
Harding, Stephen E et al (2012) Carbohydr Polym 90:237–242
Hestrin S (1949) J Biol Chem 180:249–261
Heyns K, Kiessling G (1967) Carbohydr Res 3:340–353
Jansson PE, Lindberg B, Andersson M, Lindquist U, Henrichsen J (1988) Carbohydr Res 182:111–117
Jansson PE, Lindberg B, Lindquist U (1985) Carbohydr Res 140:101–110
Jennings HJ, Rosell K-G, Carlo DJ (1980) Can J Chem 58:1069–1074
Jones C (1995) Carbohydr Res 269:175–181
Jones C, Currie F, Forster MJ (1991) Carbohydr Res 221:9121
Jones C, Lemercinier X (2002) J Pharm Biomed Anal 30:1233–1247
Jones C, Lemercinier X (2005) Carbohydr Res 340:403–409
Jones C, Whitley C, Lemercinier X (2000) Carbohydr Res 325:192–201
Jones CJ (2005) An Acad Bras Cienc 77:293–324
Jones JKN, Perry MB (1957) J Am Chem Soc 79:2787–2793
Kabat EA (1967) Experimental immunochemistry. In: Kabat EA, Mayer M (eds) Academic Press, New York, pp 538–543
Kao G, Tsai C-M (2004) Vaccine 22:335–344
Karisson C, Jansson P-E, SØrensen UBS (1999) Eur J Biochem 265:1091–1097
Kamerling JP, Tomasz A (2000) Pneumococcal polysaccharide: a chemical view–Streptococcus pneumoniae–molecular biology and mechanisms of disease. Mary Ann Lierbert, Inc., Larchmont, pp 81–114
Katzenellenbogen E, Jennings HJ (1983) Carbohydr Res 124:235–245
Kenne L, Lindberg B, Madden JK (1979) Carbohydr Res 73:175–182
Kim JS, Laskowich ER, Arumugham RG, Kaiser RE, MacMichael GJ (2005) Anal Biochem 347:247–272
Lamb DH, Lei QP, Hakim N, Rizzo S, Cash P (2005) Anal Biochem 338:263–269
Lee C-J (1983) J Biol Stand. 11:55–64
Lee C-J (1984) J Biol Stand 12:447–450
Lei QP, Shannon AG, Heller RK, Lamb DH (2000) Dev Biol 103:259–264
Lemercinier X, Jones C (1996) Carbohydr Res 296:83–96
Lemercinier XA, Jones C (2006) Carbohydr Res 341:68–74
Leontein K, Lindberg B, Lonngren J (1981) Can J Chem 59:2081–2085
Lindberg B (1990) Thesis, Stockholm University
Lindberg B, Lindquist B, Lonngren J, Powell DA (1977) Carbohydr Res 58:177–186
MacNair JE, Desai T, Teyral J, Abeygunawardana C, Hennessey JP Jr (2005) Biologicals 33:49–58
Merkle RK, Poppe I (1994) Methods Enzymol 230:1–15
Micoli F, Rondini S, Pisoni I, Proietti D, Berti F, Costantino P, Rappuoli R, Szu S, Saul A, Martin LB (2011) Vaccine 29:712–720
Moreau M, Richards JC, Kniskern PJ, Pery MB (1988) Carbohydr Res 182:179–199
Oliver MB, Jones C, Larson TR, Calix JJ, Zartler ER, Yother J, Nahm MH (2013) J Biol Chem 288:21945–21954
Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MCC, Nahm MH (2007) J Clin Micro 45:1225–1233
Reeves RE, Goebel WF (1941) J Biol Chem 139:511–519
Ricci S, Bardotti A, D’Ascenzi S, Ravenscroft N (2001) Vaccine 19:1989–1997
Richards JC, Kniskern PJ, Perry MB (1984) Can J Biochem Cell Biol 62:666–677
Richards JC, Perry MB (1988) Biochem Cell Biol 66:758–771
Richards JC, Perry MB, Kniskern PJ (1989) Can J Chem 67:1038–1050
Rondel C, Marcato-Romain C-E, Girbal-Neuhauser E (2013) Water Res 47:2901–2908
Rutherford TJ, Jones C, Davies DB, Elliott AC (1991) Carbohydr Res 218:175–184
Rutherford TJ, Jones C, Davies DB, Elliott AC (1994) Carbohydr Res 265:79–96
Slonecker JH, Orentas DG (1962) Nature (London) 194:478–479
Stroop CJM, Xu Q, Retzlaff M, Abeygunawardana C, Bush CA (2002) Carbhohydr Res 337:335–344
Svennerholm L (1957) Biochem Biophys Acta 24:604–611
Swartz LA, Progar JJ, May JC (2000) Biologicals 28:227–231
Sweeney JA, Summer JS, Hennessey JP Jr (2000) Dev Biol (Basel) 103:11–26
Talaga P, Vialle S, Moreau M (2002) Vaccine 20:2474–2484
Thiébaud J, Fanget I, Jaudinaud I, Fourrichon L, Sabouraud A, Talaga P, Uhlrich S (2014) Anal Biochem 453:22–28
Tsai C-M, Gu X-X, Byrd A (1994) Vaccine 12:700–706
Turula VE Jr, Gore T, Singh S, Arumugham RG (2010) Anal Chem 82(5):1786–1792
Vipond C, Mulloy B, Rigsby P, Burkin K, Bolgiano B (2012) MenC is working group. Biologicals 40:353–363
Von-Hunolstein C, Parsi L, Bottaro D (2003) J Biochem Biophys Methods 56:291–296
Walford SN (2010) Proc Int Soc Sug Cane Techno 27:1–15
Warren I, Odin L (1959) J Biol Chem 234:1971
WHO (1966) Technical report, no. 323
WHO (2012) Information and surveillance bulletin, vol 5, Feb 2012
Xie O, Bolgiano B, Gao F, Lockyer K, Swann C, Jones C, Delrieu I, Njanpop-Lafourcade B-M, Tamekloe TA, Pollare AJ, Norheim G (2012) Vaccine 30:5812–5823
Xu Q, Abeygunawardana C, Ng AS, Sturgess AW, Harmon BJ, Hennessey JP (2005) Anal Biochem 336:262–272 (Jan 15)
Zartler ER, Porambo RJ, Anderson CL, Chen LH, Yu J, Nahm MH (2009) J Biol Chem 284:7318–7329
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zablackis, E., Talaga, P., Singh, S. (2015). Bacterial Polysaccharide Vaccines: Analytical Perspectives. In: Nunnally, B., Turula, V., Sitrin, R. (eds) Vaccine Analysis: Strategies, Principles, and Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45024-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-45024-6_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45023-9
Online ISBN: 978-3-662-45024-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)